Labcorp Holdings Inc. (LON:0JSY)

Market Cap	15.26B
Revenue (ttm)	10.39B
Net Income (ttm)	595.88M
Shares Out	n/a
EPS (ttm)	7.06
PE Ratio	25.60
Forward PE	n/a
Dividend	2.26 (0.95%)
Ex-Dividend Date	Feb 27, 2025

Volume	116
Average Volume	139
Open	232.34
Previous Close	236.98
Day's Range	232.32 - 236.88
52-Week Range	195.90 - 242.36
Beta	1.11
RSI	47.42
Earnings Date	Apr 24, 2025

About Labcorp Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1995
• Employees: 70,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0JSY

Financial Performance

In 2024, Labcorp Holdings's revenue was $13.01 billion, an increase of 6.97% compared to the previous year's $12.16 billion. Earnings were $746.00 million, an increase of 78.47%.

Financial numbers in USD